Close Menu

biomarker discovery

NEW YORK (GenomeWeb News) – Oxford BioDynamics and the University of Glasgow today announced a partnership to identify biomarkers for the differentiation of responders from non-responders to methotrexate in the treatment of rheumatoid arthritis.

NEW YORK (GenomeWeb News) – Cancer Research UK's commercial arm, Cancer Research Technology (CRT), will partner with the biomarker validation firm Abcodia to develop blood tests for detecting early-stage cancers, CRUK said today.

NEW YORK (GenomeWeb News) – In an effort to help move biomedical innovations from the lab to the clinic more swiftly, a large group of European institutions have formed a consortium that will share access to research infrastructure and expertise, the European Commission said yesterday.

NEW YORK (GenomeWeb News) – Qiagen and SIP Biotech Development today announced the opening of the Qiagen Translational Medicine Center in Suzhou, China.

NEW YORK (GenomeWeb News) – Cenix BioScience and Debiopharm Group today announced a research agreement to use Cenix's technology in support of Debiopharm's drug development efforts.

NEW YORK (GenomeWeb News) – The National Institute of Diabetes, Digestive, and Kidney Diseases has established a biosample and data repository using samples from many of the clinical studies and trials it has funded, and it now

NEW YORK (GenomeWeb News) – The Ontario Institute for Cancer Research said today that it will collaborate with Johnson & Johnson company Janssen to conduct clinical trials aimed at identifying new prostate cancer biomarkers.

NEW YORK (GenomeWeb News) – Companion diagnostics firm Oxford Cancer Biomarkers on Monday announced a biomarker discovery deal with AstraZeneca directed at an undisclosed drug.

NEW YORK (GenomeWeb News) – The French government has provided €13.4 million ($17.4 million) to fund the Innovative MODels Initiative (IMODI), a partnership aimed at facilitating the development of new cancer treatments.

NEW YORK (GenomeWeb News) – A Brigham and Women's Hospital researcher has won $2.6 million in funding from the National Institute of Neurological Diseases and Stroke to search for biomarkers for Parkinson's disease and to share data from its Parkinson's biobank with other researchers.

Pages

A small, early-stage trial of a combination therapy for brain cancer reports favorable responses in two patients, according to the Guardian.

Nature News writes that viral genomic surveillance in the US faces systemic issues.

President Joe Biden is seeking an increase in federal spending, including higher budgets for the National Institutes of Health and Centers for Disease Control and Prevention.

In PLOS this week: sex-stratified genome-wide association study of chronic pain, sequencing data from Indigenous Mexican groups, and more.